Related Experiment Video

Updated: Jun 12, 2026

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
09:22

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

18.9K

SARS-CoV-2's influence on tau and Αβ1-42 measurements: A novel potential confounder for the AT(N) framework

George D Vavougios1, Andreas Liampas1, Vasilis-Spyridon Tseriotis2

  • 1Medical School, University of Cyprus, 75 Kallipoleos Street, P.C. 1678, Lefkosia, Cyprus.

Brain, Behavior, and Immunity
|October 9, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Alzheimer’s diseaseBeta-amyloidCOVID-19Cognitive impairmentDiagnostic criteriaNeurogenesisTau

More Related Videos

In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening09:49

In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening

Published on: November 20, 2018

19.7K
Modulation of Tau Subcellular Localization as a Tool to Investigate the Expression of Disease-related Genes09:12

Modulation of Tau Subcellular Localization as a Tool to Investigate the Expression of Disease-related Genes

Published on: December 20, 2019

6.7K

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...